|
|
|
Volumn 28, Issue 4, 1996, Pages 2177-2182
|
|
Safety and tolerability of neoral in transplant recipients
a
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
AZATHIOPRINE;
CYCLOSPORIN A;
IMMUNOSUPPRESSIVE AGENT;
ADULT;
AGED;
AREA UNDER THE CURVE;
CLINICAL TRIAL;
CONFERENCE PAPER;
DOUBLE BLIND PROCEDURE;
DRUG ABSORPTION;
DRUG BIOAVAILABILITY;
DRUG BLOOD LEVEL;
DRUG FORMULATION;
DRUG SAFETY;
EMULSION;
FEMALE;
GRAFT REJECTION;
HUMAN;
IMMUNOSUPPRESSIVE TREATMENT;
KIDNEY TRANSPLANTATION;
MAJOR CLINICAL STUDY;
MALE;
MULTICENTER STUDY;
ORAL DRUG ADMINISTRATION;
PRIORITY JOURNAL;
TREATMENT OUTCOME;
ADMINISTRATION, ORAL;
ADULT;
AGED;
AZATHIOPRINE;
CYCLOSPORINE;
DOUBLE-BLIND METHOD;
FEMALE;
HUMANS;
IMMUNOSUPPRESSIVE AGENTS;
KIDNEY TRANSPLANTATION;
LIVER TRANSPLANTATION;
MALE;
METABOLIC CLEARANCE RATE;
MIDDLE AGED;
STEROIDS;
|
|
EID: 0029809033
PISSN: 00411345
EISSN: None
Source Type: Journal
DOI: None Document Type: Conference Paper |
|
Times cited : (14)
|
|
References (0)
|
